Moreover, our research has a limitation in that the bioinformatics analysis for SLC16A1 was based on the RNA-seq data from the knockdown of SLC16A1 in human breast cancer, which weakened the biological process predictions of pancreatic cancer. This evidence concerns the gene SLC16A1 and familial pancreatic carcinoma.